Veterinary Antibiotics Market Size, Share, Industry, Forecast and outlook (2024-2031)

Report Overview

Global Veterinary Antibiotics Market reached US$ 1.5 billion in 2023 and is expected to reach US$ 2.2 billion by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.

Veterinary antibiotics are crucial in animal healthcare for treating and preventing infections caused by bacteria, parasites, and other pathogens. They promote livestock health and productivity, ensuring food safety. They are sometimes administered to groups to prevent disease spread in farming environments. However, overuse of antibiotics has raised concerns about antimicrobial resistance, leading to stricter regulations and a focus on responsible antibiotic usage in the veterinary field.

Market Scope

For more details on this report – Request for Sample

Market Dynamics: Drivers & Restraints

Rise in the prevalence of zoonotic diseases

The global veterinary antibiotics market is experiencing a surge due to the increasing prevalence of zoonotic diseases, which are transmitted from animals to humans. These diseases pose risks to animal health and public health, leading to a greater focus on preventing and controlling infections in livestock and companion animals. Veterinary antibiotics play a crucial role in managing these infections, minimizing transmission to humans, and ensuring food safety by preventing outbreaks in farm animals. This growing concern has led to increased demand for preventive and therapeutic treatments, fueling the global veterinary antibiotics market.

For instance, according to NCBI, in 2023, Zoonotic diseases are responsible for 2.5 billion human cases globally and approximately 2.7 billion deaths annually. Surveillance of animal handlers and livestock for zoonotic pathogens contributes to understanding the true disease burden and risk factors within a community. 

Stringent Regulations

The global veterinary antibiotics market faces challenges due to overuse, stricter regulations, increased demand for antibiotic-free food, and the wider application of disease reduction methods, which are exacerbated by growing concerns over antibiotic overuse.

Market Segment Analysis

The global veterinary antibiotics market is segmented based on product type, animal type, route of administration, end user, and region.

The anti-bacterial from the product type segment accounted for approximately 41.3% of the veterinary antibiotics  market share

The anti-bacterial from the product type segment accounted for approximately 41.3%. Anti-bacterial agents are vital in the global veterinary antibiotics market, preventing and treating bacterial infections in livestock and companion animals. They improve health and economic outcomes by preventing diseases that could spread rapidly. In the livestock industry, these agents ensure healthier animals, increased productivity, and better food safety. 

However, antibiotic resistance has led to stricter regulations and the development of more targeted solutions to reduce excessive usage while maintaining effectiveness. This is shaping the market's future, with innovations focusing on safer, more sustainable antibacterial approaches.

For instance, in February 2024, - Blacksmith Medicines, Inc, a leading biopharma dedicated to discovering and developing medicines targeting metalloenzymes, and Zoetis, the world's leading animal health company, announced a collaboration to discover and develop novel antibiotics for animal health.

Market Geographical Analysis

North America is estimated to hold about 41.04% of the total market share hroughout the forecast period

North America is estimated to hold about 41.04% of the total market share throughout the forecast period due to FDA approvals, rising requirement for antibiotics in veterinary treatments & surgeries, disease prevention, control of disease outbreaks to reduce the severity of disease in animals, and the increasing number of animal healthcare centers & practitioners. 

For instance, in October 2023 the FDA has approved bedinvetmab injection and Oclacitinib chewable tablets for dogs to control pain associated with osteoarthritis and pruritus. Bedinvetmab is the first monoclonal antibody (mAb) approved for use in dogs, while Oclacitinib is the first chewable treatment for allergic itch and inflammation in dogs aged 1 year or older. Both veterinary drugs are now available for prescription by veterinarians in the US.

Market Segmentation

By Product Type

• Anti-parasitic
• Anti-bacterial
• Non-steroidal anti-inflammatory Drug
• Others

By Animal Type

• Companion Animals
• Livestock Animals

By Route of Administration

• Oral
• Injection
• Topical
• Others

By End User

• Veterinary Clinics
• Veterinary Hospitals
• Others 

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Market Competitive Landscape

The major global players in the market include Bayer AG, Boehringer Ingelheim GmbH, Ceva Sante Animale S.A., Dechra Pharmaceuticals PLC, Elanco Animal Health (Eli Lilly Company), Merck & Co. Inc, Sanofi S.A, Vetoquinol S.A, Virbac SA, Zoetis, Inc  among others.

Key Developments

• In April 2024, the U.S. Food and Drug Administration approved Pradalex (pradofloxacin injection) solution for certain respiratory diseases in cattle and swine. Pradofloxacin is a medically important antimicrobial in the fluoroquinolone class and may only be prescribed by a licensed veterinarian as a single injection.

Why Purchase the Report?

• To visualize the global veterinary antibiotics market segmentation based on product type, animal type, route of administration, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of the veterinary antibiotics market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global veterinary antibiotics market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies